{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:09:23Z","timestamp":1789034963924,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j intensive care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Device-related complications remain frequent during Impella support. Although coordinated multidisciplinary care and standardized protocols are recommended for cardiogenic shock, Impella-specific management pathways have not been established. We evaluated implementation of a standardized Impella-specific management pathway (SIM) and the accompanying changes in care processes and in-hospital outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center, before-and-after observational study included 190 consecutive patients with cardiogenic shock treated with Impella, 88 before implementation and 102 after SIM introduction. SIM combined multidisciplinary education and implementation support, peri-implant strategy, access-site and limb-perfusion management, hemolysis surveillance, and hemodynamic optimization. The primary endpoint was all-cause in-hospital mortality, and the key secondary endpoint was Impella-related Bleeding Academic Research Consortium type 3 or 5 bleeding. Both were analyzed using overlap-weighted cause-specific Cox models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After SIM introduction, pre-PCI Impella use among patients with acute myocardial infarction increased from 36.2 to 76.2%, and 16-Fr sheath use increased from 0 to 80.2%. The rate of detected hemolysis increased progressively, whereas the time spent outside the target ranges for mean arterial pressure and central venous pressure decreased. After overlap weighting, all covariates included in the propensity-score model were balanced (absolute standardized mean difference &lt;0.10). In-hospital death occurred in 58.0% before implementation and 33.3% after SIM introduction (hazard ratio, 0.51; 95% confidence interval, 0.32\u20130.84;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.009). No significant interaction was observed according to SCAI shock stage, arrest or ECPELLA status at Impella insertion. Impella-related type 3 or 5 bleeding occurred in 30.7 and 12.7%, respectively (hazard ratio, 0.33; 95% confidence interval, 0.16\u20130.67;\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.002). BARC type 5 bleeding, acute limb ischemia, and stroke did not differ significantly.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SIM was progressively implemented across the catheterization laboratory and ICU, accompanied by measurable changes in care processes and lower rates of major bleeding and in-hospital death. Prospective multicenter studies should assess whether these findings are reproducible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40560-026-00937-9","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:20:02Z","timestamp":1789032002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of a standardized Impella-specific management pathway in cardiogenic shock"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-327X","authenticated-orcid":false,"given":"Kenji","family":"Kanenawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Isotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihito","family":"Oyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Korai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Tsumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-853X","authenticated-orcid":false,"given":"Takehiko","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimasa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kakumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Domei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-8205","authenticated-orcid":false,"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"937_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"JS Hochman","year":"1999","unstructured":"Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. Shock investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625\u201334.","journal-title":"N Engl J Med"},{"key":"937_CR2","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. Pci strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377:2419\u201332.","journal-title":"N Engl J Med"},{"key":"937_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779\u201389.","journal-title":"N Engl J Med"},{"key":"937_CR4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","volume":"389","author":"H Thiele","year":"2023","unstructured":"Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al. Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 2023;389:1286\u201397.","journal-title":"N Engl J Med"},{"key":"937_CR5","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287\u201396.","journal-title":"N Engl J Med"},{"key":"937_CR6","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","volume":"390","author":"JE Moller","year":"2024","unstructured":"Moller JE, Engstrom T, Jensen LO, Eiskjaer H, Mangner N, Polzin A, et al. Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med. 2024;390:1382\u201393.","journal-title":"N Engl J Med"},{"key":"937_CR7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa2515704","volume":"394","author":"D Perera","year":"2026","unstructured":"Perera D, Ryan M, Ezad SM, Khan SQ, Webb I, O\u2019Kane PD, et al. Left ventricular unloading in high-risk percutaneous coronary intervention. N Engl J Med. 2026;394:1779\u201389.","journal-title":"N Engl J Med"},{"issue":"1","key":"937_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2026.03.071","volume":"88","author":"NK Kapur","year":"2026","unstructured":"Kapur NK, Mangner N, Aghili N, Faraz H, McElwee S, Nazir R, et al. Left ventricular unloading in anterior st-segment elevation myocardial infarction without shock: The st-segment elevation myocardial infarction door to unload randomized controlled trial. J Am Coll Cardiol. 2026;88(1):76\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jcin.2025.10.051","volume":"19","author":"R Sorensen","year":"2026","unstructured":"Sorensen R, Moller JE, Vandenbriele C, Hassager C, Eiskjaer H, Mangner N, et al. Bleeding in patients with infarct-related cardiogenic shock: a danger shock substudy. JACC Cardiovasc Interv. 2026;19:302\u201312.","journal-title":"JACC Cardiovasc Interv"},{"key":"937_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.125.015676","volume":"19","author":"T Suzuki","year":"2026","unstructured":"Suzuki T, Asano T, Shinozaki T, Kohsaka S, Nakashima T, Ono M, et al. Prognostic implications of bleeding and ischemic complications in acute myocardial infarction-related cardiogenic shock managed with microaxial flow pump. Circ Cardiovasc Interv. 2026;19:e015676.","journal-title":"Circ Cardiovasc Interv"},{"key":"937_CR11","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1161\/CIRCULATIONAHA.124.072370","volume":"150","author":"E Zweck","year":"2024","unstructured":"Zweck E, Hassager C, Beske RP, Jensen LO, Eiskjaer H, Mangner N, et al. Microaxial flow pump use and renal outcomes in infarct-related cardiogenic shock: a secondary analysis of the danger shock trial. Circulation. 2024;150:1990\u20132003.","journal-title":"Circulation"},{"key":"937_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04853-y","volume":"28","author":"E Lusebrink","year":"2024","unstructured":"Lusebrink E, Lanz H, Thiele H. Scrutinizing mechanical circulatory support in cardiogenic shock: have we jumped the gun? Crit Care. 2024;28:80.","journal-title":"Crit Care"},{"key":"937_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.aicoj.2026.100038","volume":"16","author":"N Aissaoui","year":"2026","unstructured":"Aissaoui N, Delmas C, Merdji H, Schurtz G, Baudry G, Beurton A, et al. Experts\u2019 recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care. 2026;16:100038.","journal-title":"Ann Intensive Care"},{"key":"937_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jacc.2018.12.084","volume":"73","author":"BN Tehrani","year":"2019","unstructured":"Tehrani BN, Truesdell AG, Sherwood MW, Desai S, Tran HA, Epps KC, et al. Standardized team-based care for cardiogenic shock. J Am Coll Cardiol. 2019;73:1659\u201369.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","volume":"8","author":"BN Tehrani","year":"2020","unstructured":"Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and comprehensive approach to the management of cardiogenic shock. JACC Heart Fail. 2020;8:879\u201391.","journal-title":"JACC Heart Fail"},{"key":"937_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037742","volume":"14","author":"C Leung","year":"2025","unstructured":"Leung C, Fong YH, Chiang MCS, Wong IMH, Ho CB, Yeung YK, et al. Protocol-driven best practices and cardiogenic shock survival in Asian patients. J Am Heart Assoc. 2025;14:e037742.","journal-title":"J Am Heart Assoc"},{"key":"937_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s13054-026-06202-7","volume":"30","author":"K Kanenawa","year":"2026","unstructured":"Kanenawa K, Isotani A, Matsui K, Miyamoto K, Miyahara K, Oyanagi N, et al. A local complication-prevention pathway for impella-supported cardiogenic shock: a single-center experience. Crit Care. 2026;30:373.","journal-title":"Crit Care"},{"key":"937_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2020.12.054","volume":"77","author":"T Balthazar","year":"2021","unstructured":"Balthazar T, Vandenbriele C, Verbrugge FH, Den Uil C, Engstrom A, Janssens S, et al. Managing patients with short-term mechanical circulatory support: Jacc review topic of the week. J Am Coll Cardiol. 2021;77:1243\u201356.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR19","first-page":"454","volume":"91","author":"MB Basir","year":"2018","unstructured":"Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91:454\u201361.","journal-title":"Catheter Cardiovasc Interv"},{"key":"937_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031401","volume":"12","author":"MB Basir","year":"2023","unstructured":"Basir MB, Lemor A, Gorgis S, Patel KC, Kolski BC, Bharadwaj AS, et al. Early utilization of mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the national cardiogenic shock initiative. J Am Heart Assoc. 2023;12:e031401.","journal-title":"J Am Heart Assoc"},{"key":"937_CR21","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","volume":"146","author":"BJ Geller","year":"2022","unstructured":"Geller BJ, Sinha SS, Kapur NK, Bakitas M, Balsam LB, Chikwe J, et al. Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2022;146:e50\u201368.","journal-title":"Circulation"},{"key":"937_CR22","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00380-025-02514-w","volume":"40","author":"Y Tanizaki","year":"2025","unstructured":"Tanizaki Y, Fukutomi M, Onishi T, Ando T, Takanashi S, Tobaru T. Efficacy of a 16 fr sheath strategy during impella support to reduce access site bleeding in patients with cardiogenic shock. Heart Vessels. 2025;40:736\u201343.","journal-title":"Heart Vessels"},{"key":"937_CR23","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.jvs.2016.10.059","volume":"65","author":"KM Lamb","year":"2017","unstructured":"Lamb KM, DiMuzio PJ, Johnson A, Batista P, Moudgill N, McCullough M, et al. Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation. J Vasc Surg. 2017;65:1074\u20139.","journal-title":"J Vasc Surg"},{"key":"937_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MAT.0000000000000532","volume":"63","author":"DJ Kim","year":"2017","unstructured":"Kim DJ, Cho YJ, Park SH, Lim C, Park KH, Jheon S, et al. Near-infrared spectroscopy monitoring for early detection of limb ischemia in patients on veno-arterial extracorporeal membrane oxygenation. ASAIO J. 2017;63:613\u20137.","journal-title":"ASAIO J"},{"key":"937_CR25","first-page":"851","volume":"53","author":"L Baldetti","year":"2024","unstructured":"Baldetti L, Labanca R, Belletti A, Dias-Frias A, Peveri B, Kotani Y, et al. Haptoglobin administration for intravascular hemolysis: a systematic review. Blood Purif. 2024;53:851\u20139.","journal-title":"Blood Purif"},{"key":"937_CR26","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1213\/ANE.0000000000002093","volume":"124","author":"K Kubota","year":"2017","unstructured":"Kubota K, Egi M, Mizobuchi S. Haptoglobin administration in cardiovascular surgery patients: its association with the risk of postoperative acute kidney injury. Anesth Analg. 2017;124:1771\u20136.","journal-title":"Anesth Analg"},{"key":"937_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03894-5","volume":"26","author":"JA Graw","year":"2022","unstructured":"Graw JA, Hildebrandt P, Krannich A, Balzer F, Spies C, Francis RC, et al. The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO. Crit Care. 2022;26:50.","journal-title":"Crit Care"},{"key":"937_CR28","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.jcin.2023.05.043","volume":"16","author":"CJ Van Edom","year":"2023","unstructured":"Van Edom CJ, Gramegna M, Baldetti L, Beneduce A, Castelein T, Dauwe D, et al. Management of bleeding and hemolysis during percutaneous microaxial flow pump support: a practical approach. JACC Cardiovasc Interv. 2023;16:1707\u201320.","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"937_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-020-2770-5","volume":"24","author":"C-Y Chen","year":"2020","unstructured":"Chen C-Y, Zhou Y, Wang P, Qi E-Y, Gu W-J. Elevated central venous pressure is associated with increased mortality and acute kidney injury in critically ill patients: a meta-analysis. Crit Care. 2020;24(1):80.","journal-title":"Crit Care"},{"key":"937_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. Scai shock stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American college of cardiology (acc), American college of emergency physicians (acep), American heart association (aha), European society of cardiology (esc) association for acute cardiovascular care (acvc), international society for heart and lung transplantation (ishlt), society of critical care medicine (sccm), and society of thoracic surgeons (sts) in December 2021. J Am Coll Cardiol. 2022;79:933\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"937_CR31","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123:2736\u201347.","journal-title":"Circulation"},{"key":"937_CR32","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ. Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323:2417\u20138.","journal-title":"JAMA"}],"container-title":["Journal of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40560-026-00937-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40560-026-00937-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:20:04Z","timestamp":1789032004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40560-026-00937-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["937"],"URL":"https:\/\/doi.org\/10.1186\/s40560-026-00937-9","relation":{},"ISSN":["2052-0492"],"issn-type":[{"value":"2052-0492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol and opt-out approach were approved by the Institutional Review Board of Kokura Memorial Hospital (approval no. 25120501), which waived the requirement for written informed consent. The study was conducted in accordance with the Declaration of Helsinki. The broader institutional registry was registered with the University Hospital Medical Information Network (UMIN000061600).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}